Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Single arm Phase I/II multicentric open labeled, with translational sub-study, of avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients..
Epistemonikos ID: 9d8cec8ab3bad2fbe1c0c1a6caaa474a7bfd7d75
First added on: May 20, 2024